Trial Profile
A phase II/III trial of RAP-101 in Progressive Multifocal Leukoencephalopathy (PML)
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs DAPTA (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Registrational; Therapeutic Use
- 28 Apr 2016 New trial record